Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
5.10
-0.12 (-2.30%)
Sep 8, 2026, 11:37 AM EDT - Market open
Champions Oncology Employees
Champions Oncology had 214 employees as of April 30, 2026. The number of employees increased by 1 or 0.47% compared to the previous year.
Employees
214
Change (1Y)
1
Growth (1Y)
0.47%
Revenue / Employee
$277,687
Profits / Employee
-$5,491
Market Cap
70.86M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Apr 30, 2026 | 214 | 1 | 0.47% |
| Apr 30, 2025 | 213 | 3 | 1.43% |
| Apr 30, 2024 | 210 | -20 | -8.70% |
| Apr 30, 2023 | 230 | 0 | - |
| Apr 30, 2022 | 230 | 36 | 18.56% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pliant Therapeutics | 49 |
| Spero Therapeutics | 25 |
| NeurAxis | 24 |
| INmune Bio | 21 |
| LeonaBio | 19 |
| Serina Therapeutics | 16 |
| Cingulate | 14 |
| BioRestorative Therapies | 14 |
CSBR News
- 4 days ago - Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026 - Accesswire
- 7 days ago - Champions Oncology expands integrated radiopharmaceutical development platform - TheFly
- 11 days ago - Champions Oncology Proxy statement: Proxy filing - Filings
- 11 days ago - Champions Oncology Proxy statement: Proxy filing - Filings
- 6 weeks ago - Champions Oncology reports Q4 adjusted EPS 1c vs. (8c) last year - TheFly
- 6 weeks ago - Champions Oncology Earnings Call Transcript: Q4 2026 - Transcripts
- 6 weeks ago - Champions Oncology Earnings release: Q4 2026 - Filings
- 6 weeks ago - Champions Oncology Annual report: Q4 2026 - Filings